rs148276213

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_020223.4(FAM20C):​c.1228T>A​(p.Ser410Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00596 in 1,535,878 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0057 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0060 ( 40 hom. )

Consequence

FAM20C
NM_020223.4 missense

Scores

1
10
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:6

Conservation

PhyloP100: 7.07

Publications

11 publications found
Variant links:
Genes affected
FAM20C (HGNC:22140): (FAM20C golgi associated secretory pathway kinase) This gene encodes a member of the family of secreted protein kinases. The encoded protein binds calcium and phosphorylates proteins involved in bone mineralization. Mutations in this gene are associated with the autosomal recessive disorder Raine syndrome. [provided by RefSeq, Apr 2014]
FAM20C Gene-Disease associations (from GenCC):
  • lethal osteosclerotic bone dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_020223.4
BP4
Computational evidence support a benign effect (MetaRNN=0.015020758).
BP6
Variant 7-256004-T-A is Benign according to our data. Variant chr7-256004-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 289269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00575 (875/152224) while in subpopulation NFE AF = 0.00653 (444/68010). AF 95% confidence interval is 0.00603. There are 13 homozygotes in GnomAd4. There are 489 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM20CNM_020223.4 linkc.1228T>A p.Ser410Thr missense_variant Exon 6 of 10 ENST00000313766.6 NP_064608.2 Q8IXL6-1
FAM20CXR_001744837.2 linkn.*69T>A downstream_gene_variant
FAM20CXR_007060116.1 linkn.*69T>A downstream_gene_variant
FAM20CXR_007060117.1 linkn.*55T>A downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM20CENST00000313766.6 linkc.1228T>A p.Ser410Thr missense_variant Exon 6 of 10 1 NM_020223.4 ENSP00000322323.5 Q8IXL6-1
FAM20CENST00000515795.1 linkn.885T>A non_coding_transcript_exon_variant Exon 3 of 7 1
FAM20CENST00000512382.1 linkn.-191T>A upstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.00576
AC:
876
AN:
152106
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0318
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00653
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00481
AC:
674
AN:
140078
AF XY:
0.00492
show subpopulations
Gnomad AFR exome
AF:
0.00134
Gnomad AMR exome
AF:
0.000489
Gnomad ASJ exome
AF:
0.00144
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0346
Gnomad NFE exome
AF:
0.00560
Gnomad OTH exome
AF:
0.00167
GnomAD4 exome
AF:
0.00598
AC:
8275
AN:
1383654
Hom.:
40
Cov.:
32
AF XY:
0.00589
AC XY:
4020
AN XY:
682786
show subpopulations
African (AFR)
AF:
0.00108
AC:
34
AN:
31590
American (AMR)
AF:
0.000701
AC:
25
AN:
35678
Ashkenazi Jewish (ASJ)
AF:
0.00123
AC:
31
AN:
25140
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35726
South Asian (SAS)
AF:
0.00490
AC:
388
AN:
79228
European-Finnish (FIN)
AF:
0.0331
AC:
1125
AN:
33998
Middle Eastern (MID)
AF:
0.00106
AC:
6
AN:
5668
European-Non Finnish (NFE)
AF:
0.00592
AC:
6381
AN:
1078742
Other (OTH)
AF:
0.00492
AC:
285
AN:
57884
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
544
1088
1633
2177
2721
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00575
AC:
875
AN:
152224
Hom.:
13
Cov.:
33
AF XY:
0.00657
AC XY:
489
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41532
American (AMR)
AF:
0.000588
AC:
9
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
0.0318
AC:
337
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00653
AC:
444
AN:
68010
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00517
Hom.:
1
Bravo
AF:
0.00305
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00649
AC:
25
ESP6500AA
AF:
0.00145
AC:
2
ESP6500EA
AF:
0.00817
AC:
26
ExAC
AF:
0.00338
AC:
83
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Lethal osteosclerotic bone dysplasia Pathogenic:1Benign:2
May 04, 2023
Molecular Genetics, Royal Melbourne Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

European Non-Finnish population allele frequency is 0.5092% (rs148276213, 674/140078 alleles, 2 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as LIKELY BENIGN. Following criteria are met: BS1 -

Aug 09, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 17, 2017
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The observed mutation is reported in 1000 Genomes and ExAC databases. The in silico prediction of the mutation is damaging by MutationTaster2 and PROVEAN. The given mutation is probably damaging by Polyphen2 and it is benign by SIFT. The dbSNP reference number of the given mutation is rs148276213. The proband, born of a third degree consanguinity, presented with facial dysmorphism, mild hypotonia and microcephaly. Her CT-scan report showed mild cortical atrophy. Her EEG and karyotype were normal. She was found normal for William syndrome. Her array CGH report showed no quantitative genomic imbalance. She was observed to have chronic constipation, hyperactive behavior, two episodes of seizures, delay in speech, delay in cognitive and motor milestones. Her MRI report showed corpus callosal dysgenesis with absent rostral area. She was also detected with intrauterine growth restriction (IUGR). She was born through Lower segment Cesarian section (LSCS). She presented no neonatal difficulties. Her parents were found to be heterozygous for this allele. -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FAM20C: BS1, BS2 -

not specified Benign:1
Aug 30, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.82
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.090
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.45
T
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.89
D
MetaRNN
Benign
0.015
T
MetaSVM
Uncertain
-0.19
T
PhyloP100
7.1
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-2.7
D
REVEL
Uncertain
0.57
Sift
Benign
0.31
T
Sift4G
Benign
0.23
T
Polyphen
0.97
D
Vest4
0.69
MVP
0.79
MPC
1.2
ClinPred
0.014
T
GERP RS
4.9
Varity_R
0.42
gMVP
0.89
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148276213; hg19: chr7-295970; API